-
Pragmatic Clinical Trials Need Their Own Set Of Rules
May 12 | Clinical Research News | Pragmatic clinical trials (PCTs) require a more nuanced playbook than traditional explanatory studies when it comes to informed consent and respect for individuals. New models for engagement, transparency, and accountability will also be needed to accommodate the scale and heterogeneity of PCTs. More -
New ‘Research Data Mart’ To Help Academic Sites Track Trial Performance
May 10 | Clinical Research News | A university’s ability to conduct clinical trials with speed and efficiency has become a key consideration of the National Institutes of Health (NIH) when doling out grants, so the Medical University of South Carolina has created a digital platform called Research Integrated Network of Systems (RINS) to generate the kind of performance benchmarks that can help keep institutions in the running. More -
Intelligent Technology: Impacting the Future of Clinical Research
May 06 | Clinical Research News | Today’s clinical trial landscape is incredibly complex to navigate. A prevailing issue is inefficiency—relying on years of approved and proven SOPs that can result in expensive delays and increased burdens for patients, sites and sponsors. The good news is disruptive technologies—specifically artificial intelligence—are tangibly resolving challenges inherent to the clinical trial process. More -
ERT and Bioclinica Close Merger, Parexel and Veeva Collaborate, More
May 03 | Clinical Research News | Mergers and strategic collaborations link data from devices and sensors, streamline research workflows, and aim to accelerate clinical trials. Plus, updated CTMSs, expanded CROs, and more new products and updates from around the industry. More -
Why Imaging Biomarkers Represent the Next Generation of Personalized Drug Development
Apr 30 | Clinical Research News | Imaging biomarkers, which are generated through the science of radiomics (think: advanced imaging analytics), are likely to play in the future of personalized drug development. Today, private industry and academia are collaborating on research to discover and develop new imaging biomarkers to add a new layer to the personalization of medicine. More -
Seqster’s Series A, Investments in Digital Trials, and Virtual Care Delivery
Apr 29 | Clinical Research News | Medable nets cash to deliver decentralized trials; more money for telemedicine and telehealth delivery, investments in healthcare data platforms, and more. More -
Medable: Real-World Evidence Needed To Address Health Disparities
Apr 26 | Clinical Research News | The pandemic has served to highlight the value of real-world evidence (RWE) in personalizing the delivery of care and potentially reducing disparities in access to treatment options, including clinical studies. To explore this “new frontier,” Medable has contracted with Kaiser Permanente to develop mobile apps designed to capture insights from informal caregivers, and digital biomarkers from wearable devices with patients, in fully decentralized trials. More -
Biomarker Discovery Reveals Role of Lipids in Age-Related Pathologies
Apr 21 | Clinical Research News | Senescent cells can be good or bad actors when it comes to human health, but their steady accumulation with aging has adverse consequences that pharmaceutical companies are keen on reversing. Determining if a senolytic drug is working in the human body is a tough proposition, however, since the testing process often involves a biopsy and waiting long periods of time to determine whether a pathology has been ameliorated. More -
How to Make Translations Work for Everyone
Apr 19 | Clinical Research News | When conducting a clinical trial on a global scale, sponsors assume a certain amount of risk in addition to significant management challenges, many of which can be attributed to communication. For this reason, comprehensive translation strategies are important to consider prior to moving forward with a clinical trial. More -
Sanofi Reaping Rewards Of Site- And Patient-Centric Clinical Development
Apr 14 | Clinical Research News | Sanofi has succeeded in accelerating its clinical development timeline year over year, in large part by viewing patients as customers and key opinion leaders (KOLs), according to Victoria DiBiaso, vice president and regional head of the clinical studies unit in Asia Pacific, Eurasia, Middle East, and Africa. “What that means for patients is that we are developing meaningful healthcare solutions that are addressing unmet needs and we are doing it faster.” More
DIA NOW is the source for life science knowledge. Comprehensive and customizable, and backed by DIA's extensive history, global reach, and experience, you'll stay on top of trends and receive up-to-the-minute updates on a wide variety of critical issues in the life sciences arena. Get your one-month free trial today!
